NOHEMI SALINAS JAZMIN



DATOS GENERALES
Nombre completo   NOHEMI SALINAS JAZMIN
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   17 años
NOMBRAMIENTOS
Vigente   PROFESOR DE CARRERA TITULAR A TC No Definitivo
Facultad de Medicina
Desde 01-06-2021
PROFESOR DE CARRERA TITULAR A TC No Definitivo
Dirección General de Asuntos del Personal Académico
Desde 01-11-2019 hasta 31-05-2021
POSDOCTOR TC No Definitivo
Centro de Ciencias Genómicas
Desde 01-09-2018 hasta 31-08-2019
PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Química
Desde 01-01-2008 (fecha inicial de registros en el SIIA) hasta 15-08-2017
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI I2017 - VIGENTE
* EQUIVALENCIA PRIDE B2019 - 2024

INFORMACIÓN DE PUBLICACIONES
Firmas  
Salinas, N Salinas, Nohemi Salinas-Jazmín N. Salinas-Jazmin, N Salinas-Jazmin, N. Salinas-Jazmin, Nohemi
ID's SCOPUS  
24399856300 55856956800
ORCID's  
0000-0002-9870-8650
Áreas de conocimiento  
Cell and tissue engineering Chemistry, analytical Food science and technology Immunology Infectious diseases
Medicine, general and internal Multidisciplinary sciences Neurosciences Oncology Pharmacology & pharmacy
Pharmacology and pharmacy Plant sciences Toxicology Behavioral neuroscience Chemical engineering (miscellaneous)
Genetics Histology Immunology Infectious Diseases Medicine (miscellaneous)
Oncology Pharmaceutical Science Pharmacology (medical) Plant science Radiology, nuclear medicine and imaging
Toxicology
Coautorías con entidades de la UNAM  
  • Instituto de Investigaciones Biomédicas
  • Facultad de Ciencias
  • Facultad de Medicina
  • Facultad de Química
  • Facultad de Medicina Veterinaria y Zootecnia
  • Facultad de Estudios Superiores "Iztacala"
  • Dirección General de Asuntos del Personal Académico
Revistas en las que ha publicado  (18):
  1. BRAIN BEHAVIOR AND IMMUNITY, Estados Unidos America (2018)
  2. CANCER CELL INTERNATIONAL, Reino Unido (2008)
  3. CANCER CHEMOTHERAPY AND PHARMACOLOGY, Estados Unidos America (2010, 2024)
  4. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Países Bajos (2017)
  5. Frontiers in Plant Science, Suiza (2021)
  6. GACETA MEDICA DE MEXICO, México (2022)
  7. JOURNAL OF IMMUNOLOGY, Estados Unidos America (2014, 2015)
  8. JOURNAL OF IMMUNOLOGY RESEARCH, Estados Unidos America (2015)
  9. JOURNAL OF IMMUNOTOXICOLOGY, Estados Unidos America (2017)
  10. JOURNAL OF MEDICINAL FOOD, Estados Unidos America (2015)
  11. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, Países Bajos (2014)
  12. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, Estados Unidos America (2017)
  13. Methods in Molecular Biology, Estados Unidos America (2014, 2022)
  14. MICROBES AND INFECTION, Países Bajos (2015)
  15. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, Estados Unidos America (2014)
  16. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, Estados Unidos America (2021)
  17. TRANSLATIONAL CANCER RESEARCH, China (2022)
  18. World Journal of Stem Cells, Estados Unidos America (2021)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter1ᵉʳ autor: Salinas-Jazmin, N, Medina-Mondragon, MA, Jimenez-Lopez, J, Guerrero-Rodriguez, SL, et al.2024CANCER CHEMOTHERAPY AND PHARMACOLOGYWoS-id: 001297576200002
Scopus-id: 2-s2.0-85201963833
22
2Relationship between the expression of complement inhibitory proteins and therapeutic efficacy of antibodies in breast cancer2ᵒ autor y autor de correspondencia: Salinas-Jazmin, Nohemi, Montalvo-Castro, Rebeca E.2022GACETA MEDICA DE MEXICOWoS-id: 000823563000006
Scopus-id: 2-s2.0-85133881467
20
3DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implications2ᵒ autor: Salinas-Jazmín N., Rosas-Cruz A., Valdés-Rives A., Velasco-Velázquez M.A.2022TRANSLATIONAL CANCER RESEARCHWoS-id: 000879997800001
Scopus-id: 2-s2.0-85147683325
66
4Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies1ᵉʳ autor: Salinas-Jazmín N., Medina-Rivero E., Velasco-Velázquez M.A.2022Methods in Molecular BiologyScopus-id: 2-s2.0-85114618359
02
5The Entry Blocker Peptide Produced in Chlamydomonas reinhardtii Inhibits Influenza Viral Replication in vitroCoautor: Salinas-Jazmin, Nohemi, Reyes-Barrera, Karen Lizbeth, Soria-Guerra, Ruth Elena, Lopez-Martinez, Rogelio, et al.2021Frontiers in Plant ScienceWoS-id: 000654004700001
Scopus-id: 2-s2.0-85107072418
78
6Reporter gene systems for the identification and characterization of cancer stem cells1ᵉʳ autor: Salinas-Jazmin, Nohemi, Rosas-Cruz, Arely, Velasco-Velazquez, Marco2021World Journal of Stem CellsWoS-id: 000679408700009
Scopus-id: 2-s2.0-85111729027
35
7Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?2ᵒ autor: Salinas-Jazmin, Nohemi, Rosas-Cruz, Arely, Velázquez M.A.V.2021TECHNOLOGY IN CANCER RESEARCH & TREATMENTWoS-id: 000688089000001
Scopus-id: 2-s2.0-85110392301
2428
8The yin/yang of inflammatory status: Blood-brain barrier regulation during sleepCoautor: Salinas-Jazmín N., Hurtado-Alvarado G., Becerril-Villanueva E., Contis-Montes de Oca A., et al.2018BRAIN BEHAVIOR AND IMMUNITYWoS-id: 000432905200015
Scopus-id: 2-s2.0-85034840800
5154
9Extensive preclinical evaluation of an infliximab biosimilar candidate2ᵒ autor: Salinas-Jazmin, N., Velasco-Velazquez, M. A., Hisaki-Itaya, E., Cobos-Puc, L., et al.2017EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESWoS-id: 000401390900005
Scopus-id: 2-s2.0-85014178291
77
10In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis1ᵉʳ autor: Salinas-Jazmín N., González-González E., Vásquez-Bochm L.X., Pérez-Tapia S.M., et al.2017JOVE-JOURNAL OF VISUALIZED EXPERIMENTSWoS-id: 000406213900043
Scopus-id: 2-s2.0-85018934168
12
11Transferon?, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvantsCoautor: Salinas-Jazmín N., Avila S., Muñoz-García L., Vázquez-Leyva S., et al.2017JOURNAL OF IMMUNOTOXICOLOGYScopus-id: 2-s2.0-85046052210
03
12Herpes Murine Model as a Biological Assay to Test Dialyzable Leukocyte Extracts Activity1ᵉʳ autor: Salinas-Jazmin N., Estrada-Parra S., Becerril-Garcia M.A., Limon-Flores A.Y., et al.2015JOURNAL OF IMMUNOLOGY RESEARCHWoS-id: 000353776000001
Scopus-id: 2-s2.0-84929378004
1515
13Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated T(h)1 immune responseCoautor: Salinas, N, Olguin, JE, Fernandez, J, Juarez, I, et al.2015MICROBES AND INFECTIONWoS-id: 000358804300008
Scopus-id: 2-s2.0-84944358193
1919
14Swine Dialyzable Spleen Extract as Antiviral ProphylaxisCoautor: Salinas-Jazmín N., Merchand-Reyes G., Pavón L., Pérez-Sánchez G., et al.2015JOURNAL OF MEDICINAL FOODWoS-id: 000363940500008
Scopus-id: 2-s2.0-84946041684
22
15Reduction of regulatory T cells during acute Toxoplasma gondii infection is caused by IFN-gammaCoautor: Salinas, Nohemi, Olguin, Jonadab, Fernandez, Jacquelina, Terrazas, Luis, et al.2015JOURNAL OF IMMUNOLOGYWoS-id: 000379404502348
00
16Biological activity of dialyzable leukocyte extracts in a mouse cutaneous herpes model.2ᵒ autor: Salinas-Jazmin, Nohemi, Perez-Tapia, Sonia, Estrada-Parra, Sergio, Limon-Flores, Alberto, et al.2014JOURNAL OF IMMUNOLOGYWoS-id: 000209765000069
00
17T cell suppression in vitro during toxoplasma gondii infection is the result of IL-2 competition between tregs and T cells leading to death of proliferating T cells1ᵉʳ autor: Salinas, N, Olguin, JE, Castellanos, C, Saavedra, R2014SCANDINAVIAN JOURNAL OF IMMUNOLOGYWoS-id: 000328598900001
Scopus-id: 2-s2.0-84890891748
1112
18Batch-to-batch reproducibility of Transferon?Coautor: Salinas-Jazmín N., Medina-Rivero E., Merchand-Reyes G., Pavón L., et al.2014JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISWoS-id: 000329532800039
Scopus-id: 2-s2.0-84885070260
3032
19A Flow Cytometry-Based Assay for the Evaluation of Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Cancer Cells1ᵉʳ autor: Salinas-Jazmín N., Hisaki-Itaya E., Velasco-Velázquez M.A.2014Methods in Molecular BiologyWoS-id: 000338510500017
Scopus-id: 2-s2.0-84927154840
1112
20Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model1ᵉʳ autor: Salinas-Jazmín N., De La Fuente M., Jaimez R., Pérez-Tapia M., et al.2010CANCER CHEMOTHERAPY AND PHARMACOLOGYWoS-id: 000274655500014
Scopus-id: 2-s2.0-77649180895
1215
21Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells2ᵒ autor: Salinas-Jazmin, N, Velasco-Velazquez, MA, Mendoza-Patino, N, Mandoki, JJ2008CANCER CELL INTERNATIONALWoS-id: 000208405200008
Scopus-id: 2-s2.0-45749148244
2733
Descargar PDF

Documentos no indexados (Humanindex)

Descargar PDF

No se encuentran registros en la base de datos de capítulos de libros (WoS y Scopus).

Descargar PDF

No se encuentran registros en la base de datos de obras con ISBN (Indautor).

Descargar PDF

Proyectos

Descargar PDF

Participación en Comités de Tesis

Descargar PDF

Docencia Impartida

Descargar PDF

No se encuentran registros en la base de datos de patentes.

Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)